Key result
Lower preprocedural anterior HFQRS amplitude strongly predicts LBBP response and greater LVEF improvement.
Why the study?
Do preprocedural high-frequency QRS (HFQRS) parameters predict left bundle branch area pacing (LBBP) response (absolute LVEF increase >10% at 6 months) in patients with non-ischemic cardiomyopathy and LBBB?
Cohort (n=58)
Do preprocedural high-frequency QRS (HFQRS) parameters predict left bundle branch area pacing (LBBP) response (absolute LVEF increase >10% at 6 months) in patients with non-ischemic cardiomyopathy and LBBB?
Preprocedural high-frequency QRS analysis—specifically reduced anterior mean HFQRS amplitude—is independently associated with greater LVEF recovery and may serve as a noninvasive tool for patient selection in left bundle branch area pacing.
Answers are grounded in this paper and cite their sources.
Lower anterior HFQRS amplitude may identify LBBP responders; this exploratory association leaves open its role in preprocedural selection.
BACKGROUND: Left bundle branch area pacing (LBBP) has become a preferred as a novel strategy for cardiac resynchronization therapy (CRT). High-frequency QRS (HFQRS) analysis can detect subtle ventricular depolarization abnormalities that are not identifiable on standard electrocardiography and may provide novel markers for predicting response to LBBP. METHODS: We prospectively enrolled 58 consecutive patients with non-ischemic cardiomyopathy and left bundle branch block (LBBB) who underwent guideline-directed LBBP between 2022 and 2025. LBBP response was defined as an absolute increase in left ventricular ejection fraction (LVEF) >10% at 6-month follow-up. Preprocedural HFQRS parameters were quantitatively analyzed, including mean HFQRS amplitude and the high-frequency morphological index (HFMI). RESULTS: Forty-three patients (74.1%) met the criteria for LBBP response. Responders had significantly lower anterior mean HFQRS amplitude (1.61 ± 0.59 vs. 2.60 ± 1.01 μV, P = 0.002) and higher anterior HFMI (24.7% vs. 16.1%, P = 0.002) than non-responders. Anterior mean amplitude showed the strongest predictive value for LBBP response (AUC = 0.800, 95% CI 0.656-0.944). Patients with lower anterior mean amplitude demonstrated better event-free survival (log-rank P = 0.011). In multivariable analysis, lower anterior mean amplitude independently predicted greater LVEF improvement (β = -0.474, P = 0.003) and was associated with more pronounced reverse remodeling (P = 0.001). CONCLUSION: In patients with non-ischemic LBBB undergoing LBBP, reduced anterior mean HFQRS amplitude is independently associated with improved ventricular recovery and a higher likelihood of response to resynchronization therapy. HFQRS analysis may provide a useful noninvasive tool for preprocedural risk stratification and patient selection in LBBP.
No takes yet. Share an insight, caveat, or question.
Hou et al. (2026) conducted a cohort in Non-ischemic cardiomyopathy and left bundle branch block undergoing guideline-directed left bundle branch area pacing (n=58). Preprocedural high-frequency QRS (HFQRS) parameters (anterior mean HFQRS amplitude and high-frequency morphological index [HFMI]) vs. Non-responders vs. responders (or higher vs. lower anterior mean HFQRS amplitude) was evaluated on Left bundle branch area pacing (LBBP) response, defined as an absolute increase in left ventricular ejection fraction (LVEF) >10% at 6-month follow-up (AUC 0.800, 95% CI 0.656-0.944, p=0.002). Lower preprocedural anterior mean HFQRS amplitude strongly predicted LBBP response (1.61 vs 2.60 μV, P=0.002; AUC 0.800, 95% CI 0.656-0.944) and greater LVEF improvement (β=-0.474, P=0.003).
Synapse has enriched 10 related papers. Consider them for comparative context: